淋巴结转移在癌症进展:分子机制,临床意义和治疗干预措施
Haoran Ji1, Chuang Hu1, Xuhui Yang1
1Department of Thoracic Surgery, Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Signal transduction and targeted therapy
|September 26, 2023
概括
淋巴结转移 (LNM) 对于癌症的分期和预后至关重要. 了解LNM机制和临床影响有助于瘤学家对患者的评估和治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 淋巴结 (LNs) 是癌细胞转移的关键部位,影响患者的预后.
- 淋巴结转移 (LNM) 是分期,预测结果和指导各种癌症治疗的关键指标.
- 准确评估LNM对于有效的癌症管理至关重要.
研究的目的:
- 审查目前关于LNs转移的解剖学和生理学方面的知识.
- 阐明驱动瘤细胞转移到LNS的分子机制.
- 总结LNM在不同癌症类型和解剖位置的临床意义.
主要方法:
- 关于LNM的基础和临床研究的综合文献综述.
- 对LNM研究中应用的医疗技术的最新进展进行分析.
- 综合关于转移性LNs的诊断和治疗策略的信息.
主要成果:
- 详细描述 LN 特性和 LNM 的分子机制.
- 简要介绍LNM在癌症分期,预后预测和治疗选择中的作用.
- 讨论转移性LN识别和管理中的新兴策略和正在进行的辩论.
结论:
- 对于瘤学家来说,对LNM机制和临床影响的更好理解是必不可少的.
- 技术的进步正在改善LNM的诊断和治疗.
- 需要进一步的研究和讨论来完善管理转移性LNs的策略.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


